These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21807794)

  • 1. Patient perspective on remission in rheumatoid arthritis.
    van Tuyl LH; Smolen JS; Wells GA; Scholte-Voshaar M; Hoogland W; Boers M
    J Rheumatol; 2011 Aug; 38(8):1735-8. PubMed ID: 21807794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12.
    van Tuyl LH; Sadlonova M; Davis B; Flurey C; Goel N; Hewlett SE; Hill CL; Hoogland W; Kirwan JR; van Schaardenburg D; Scholte-Voshaar M; Smolen JS; Stamm T; Wells GA; Boers M
    J Rheumatol; 2016 Jan; 43(1):203-7. PubMed ID: 25684772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCID/Low Disease Activity State Workshop: low disease activity state in rheumatoid arthritis.
    Wells G; Boers M; Shea B; Anderson J; Felson D; Johnson K; Kirwan J; Lassere M; Robinson V; Simon L; Strand V; van Riel P; Tugwell P
    J Rheumatol; 2003 May; 30(5):1110-1. PubMed ID: 12734918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.
    Rasch LA; Boers M; Hill CL; Voshaar M; Hoogland W; de Wit M; Flurey C; Davis B; Hetland ML; Brahe CH; Gossec L; Wells GA; Tugwell P; Kuriya B; Goel N; Singh JA; Duarte C; Da Silva J; van Schaardenburg D; Proudman S; van Tuyl LHD;
    J Rheumatol; 2017 Dec; 44(12):1889-1893. PubMed ID: 28765250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.
    Alten R; Pohl C; Choy EH; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Sanderson TC; Strand V; Woodworth TG; Bingham CO;
    J Rheumatol; 2011 Aug; 38(8):1745-50. PubMed ID: 21807796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
    J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods used to assess remission and low disease activity in rheumatoid arthritis.
    Ometto F; Botsios C; Raffeiner B; Sfriso P; Bernardi L; Todesco S; Doria A; Punzi L
    Autoimmun Rev; 2010 Jan; 9(3):161-4. PubMed ID: 19602456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the patient perspective at OMERACT 10--conceptualizing methods for developing patient-reported outcomes.
    Kirwan JR; Tugwell PS
    J Rheumatol; 2011 Aug; 38(8):1699-701. PubMed ID: 21807788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis.
    Kirwan JR; Hewlett S
    J Rheumatol; 2007 May; 34(5):1171-3. PubMed ID: 17477481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in health.
    Kirwan JR; Boonen A; Harrison MJ; Hewlett SE; Wells GA; Singh JA; Furst DE; Dworkin RH
    J Rheumatol; 2011 Aug; 38(8):1728-34. PubMed ID: 21807793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress since OMERACT 6 on including patient perspective in rheumatoid arthritis outcome assessment.
    Kirwan JR; Ahlmén M; de Wit M; Heiberg T; Hehir M; Hewlett S; Katz PP; Minnock P; Quest EM; Richards P
    J Rheumatol; 2005 Nov; 32(11):2246-9. PubMed ID: 16265711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.
    Kirwan JR; Hewlett SE; Heiberg T; Hughes RA; Carr M; Hehir M; Kvien TK; Minnock P; Newman SP; Quest EM; Taal E; Wale J
    J Rheumatol; 2005 Nov; 32(11):2250-6. PubMed ID: 16265712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis.
    Kirwan JR; Minnock P; Adebajo A; Bresnihan B; Choy E; de Wit M; Hazes M; Richards P; Saag K; Suarez-Almazor M; Wells G; Hewlett S
    J Rheumatol; 2007 May; 34(5):1174-7. PubMed ID: 17477482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCID/Low Disease Activity State Workshop: summary, recommendations, and research agenda.
    Wells G; Anderson J; Boers M; Felson D; Heiberg T; Hewlett S; Johnson K; Kirwan J; Lassere M; Robinson V; Shea B; Simon L; Strand V; van Riel P; Tugwell P
    J Rheumatol; 2003 May; 30(5):1115-8. PubMed ID: 12734920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proposed approach to recognise "near-remission" quantitatively without formal joint counts or laboratory tests: a patient self-report questionnaire routine assessment of patient index data (RAPID) score as a guide to a "continuous quality improvement" s.
    Pincus T; Yazici Y; Bergman M; Swearingen C; Harrington T
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-60-5; quiz S-66-73. PubMed ID: 17083765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee.
    Goldsmith CH; Boers M; Bombardier C; Tugwell P
    J Rheumatol; 1993 Mar; 20(3):561-5. PubMed ID: 8478874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process.
    Fried BJ; Boers M; Baker PR
    J Rheumatol; 1993 Mar; 20(3):548-51. PubMed ID: 8478870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity.
    Wells G; Boers M; Tugwell P;
    Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-52-9. PubMed ID: 17083764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop.
    Bingham CO; Alten R; Bartlett SJ; Bykerk VP; Brooks PM; Choy E; Christensen R; Furst DE; Hewlett SE; Leong A; May JE; Montie P; Pohl C; Sanderson TC; Strand V; Woodworth TG;
    J Rheumatol; 2011 Aug; 38(8):1751-8. PubMed ID: 21807797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The patient perspective on absence of disease activity in rheumatoid arthritis: a survey to identify key domains of patient-perceived remission.
    van Tuyl LH; Sadlonova M; Hewlett S; Davis B; Flurey C; Goel N; Gossec L; Heegaard Brahe C; Hill CL; Hoogland W; Kirwan J; Hetland ML; van Schaardenburg D; Smolen JS; Stamm T; Voshaar M; Wells GA; Boers M
    Ann Rheum Dis; 2017 May; 76(5):855-861. PubMed ID: 27903508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.